CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -50.0% | 3,180 | -28.9% | 0.00% | – |
| Q1 2022 | $14,000 | -22.2% | 4,474 | +7.1% | 0.00% | – |
| Q4 2021 | $18,000 | -47.1% | 4,179 | 0.0% | 0.00% | – |
| Q3 2021 | $34,000 | +3.0% | 4,179 | -4.0% | 0.00% | – |
| Q2 2021 | $33,000 | -19.5% | 4,355 | -6.9% | 0.00% | – |
| Q1 2021 | $41,000 | +5.1% | 4,677 | -4.3% | 0.00% | – |
| Q4 2020 | $39,000 | 0.0% | 4,886 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -30.4% | 4,886 | -14.1% | 0.00% | – |
| Q2 2020 | $56,000 | +64.7% | 5,691 | +15.9% | 0.00% | – |
| Q1 2020 | $34,000 | +41.7% | 4,909 | -21.1% | 0.00% | – |
| Q4 2019 | $24,000 | -4.0% | 6,219 | +23.8% | 0.00% | – |
| Q3 2019 | $25,000 | -24.2% | 5,023 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | -13.2% | 5,023 | 0.0% | 0.00% | – |
| Q1 2019 | $38,000 | -7.3% | 5,023 | 0.0% | 0.00% | – |
| Q4 2018 | $41,000 | -25.5% | 5,023 | +18.6% | 0.00% | – |
| Q3 2018 | $55,000 | +14.6% | 4,235 | 0.0% | 0.00% | – |
| Q2 2018 | $48,000 | – | 4,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |